Ropeginterferon alfa-2b in patients with genotype 1 chronic hepatitis C: Pharmacokinetics, safety, and preliminary efficacy
- Hsien Hong Lin
- , Shih Jer Hsu
- , Sheng Nan Lu
- , Wan Long Chuang
- , Chao Wei Hsu
- , Rong Nan Chien
- , Sien Sing Yang
- , Wei Wen Su
- , Jaw Ching Wu
- , Tzong Hsi Lee
- , Cheng Yuan Peng
- , Kuan Chiao Tseng
- , Albert Qin
- , Yi Wen Huang*
- , Pei Jer Chen*
*Corresponding author for this work
- Taipei Tzu Chi Hospital
- National Taiwan University
- Chang Gung Memorial Hospital
- Kaohsiung Medical University
- Cathay General Hospital Taiwan
- Changhua Christian Hospital
- Veterans General Hospital-Taipei
- Far Eastern Memorial Hospital
- China Medical University Taichung
- A PharmaEssentia Company
- Taipei Medical University
Research output: Contribution to journal › Journal Article › peer-review
19
Scopus
citations